Based on a very large series of childhood scleroderma followed for mor
e than ten years, the authors describe various subsets, which, in seve
ral aspects, differ significantly from the adult forms. Of special imp
ortance is a higher prevalence of linear scleroderma resulting in defo
rmities and disabilities, as well as impairment of bone development in
facial hemiatrophy. The immune abnormalities and vascular involvement
leading to fibrosis are presented as the basic events in the pathogen
esis. Critical discussion on a possible transitional form between loca
lized and systemic disease and visceral involvement in cutaneous forms
is followed by clinically applicable laboratory studies and managemen
t, including new therapeutic modalities.